-
1
-
-
33748091739
-
Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics
-
Dschietzig T., Bartsch C., Baumann G., and Stangl K. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharmacol. Ther. 112 (2006) 38-56
-
(2006)
Pharmacol. Ther.
, vol.112
, pp. 38-56
-
-
Dschietzig, T.1
Bartsch, C.2
Baumann, G.3
Stangl, K.4
-
2
-
-
38749122842
-
The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease
-
Samuel C.S., Lekgabe E.D., and Mookerjee I. The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease. Adv. Exp. Med. Biol. 612 (2007) 88-103
-
(2007)
Adv. Exp. Med. Biol.
, vol.612
, pp. 88-103
-
-
Samuel, C.S.1
Lekgabe, E.D.2
Mookerjee, I.3
-
3
-
-
24644449612
-
Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model
-
Perna A.M., Masini E., Nistri S., Briganti V., Chiappini L., Stefano P., et al. Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model. FASEB J. 19 (2005) 1525-1527
-
(2005)
FASEB J.
, vol.19
, pp. 1525-1527
-
-
Perna, A.M.1
Masini, E.2
Nistri, S.3
Briganti, V.4
Chiappini, L.5
Stefano, P.6
-
4
-
-
34247639085
-
Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises
-
Nistri S., Bigazzi M., and Bani D. Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises. Cardiovasc. Hematol. Agents Med. Chem. 5 (2007) 101-108
-
(2007)
Cardiovasc. Hematol. Agents Med. Chem.
, vol.5
, pp. 101-108
-
-
Nistri, S.1
Bigazzi, M.2
Bani, D.3
-
6
-
-
39149091073
-
Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction
-
Nistri S., Cinci L., Perna A.M., Masini E., Mastroianni R., and Bani D. Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction. Pharmacol. Res. 57 (2008) 43-48
-
(2008)
Pharmacol. Res.
, vol.57
, pp. 43-48
-
-
Nistri, S.1
Cinci, L.2
Perna, A.M.3
Masini, E.4
Mastroianni, R.5
Bani, D.6
-
7
-
-
38749100594
-
Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness
-
Klonisch T., Bialek J., Radestock Y., Hoang-Vu C., and Hombach-Klonisch S. Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness. Adv. Exp. Med. Biol. 612 (2007) 104-118
-
(2007)
Adv. Exp. Med. Biol.
, vol.612
, pp. 104-118
-
-
Klonisch, T.1
Bialek, J.2
Radestock, Y.3
Hoang-Vu, C.4
Hombach-Klonisch, S.5
-
8
-
-
32544461149
-
The role of relaxin in endometrial cancer
-
Kamat A.A., Feng S., Agoulnik I.U., Kheradmand F., Bogatcheva N.V., Coffey D., et al. The role of relaxin in endometrial cancer. Cancer Biol. Ther. 5 (2006) 71-77
-
(2006)
Cancer Biol. Ther.
, vol.5
, pp. 71-77
-
-
Kamat, A.A.1
Feng, S.2
Agoulnik, I.U.3
Kheradmand, F.4
Bogatcheva, N.V.5
Coffey, D.6
-
9
-
-
34250181702
-
Relaxin promotes prostate cancer progression
-
Feng S., Agoulnik I.U., Bogatcheva N.V., Kamat A.A., Kwabi-Addo B., Li R., et al. Relaxin promotes prostate cancer progression. Clin. Cancer Res. 13 (2007) 1695-1702
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 1695-1702
-
-
Feng, S.1
Agoulnik, I.U.2
Bogatcheva, N.V.3
Kamat, A.A.4
Kwabi-Addo, B.5
Li, R.6
-
10
-
-
0034548350
-
Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland
-
Hombach-Klonisch S., Buchmann J., Sarun S., Fischer B., and Klonisch T. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland. Cancer 89 (2000) 2161-2168
-
(2000)
Cancer
, vol.89
, pp. 2161-2168
-
-
Hombach-Klonisch, S.1
Buchmann, J.2
Sarun, S.3
Fischer, B.4
Klonisch, T.5
-
11
-
-
4544357518
-
Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients
-
Binder C., Simon A., Binder L., Hagemann T., Schulz M., Emons G., et al. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res. Treat. 87 (2004) 157-166
-
(2004)
Breast Cancer Res. Treat.
, vol.87
, pp. 157-166
-
-
Binder, C.1
Simon, A.2
Binder, L.3
Hagemann, T.4
Schulz, M.5
Emons, G.6
-
12
-
-
27944447704
-
H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis
-
Silvertown J.D., Ng J., Sato T., Summerlee A.J., and Medin J.A. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int. J. Cancer 118 (2006) 62-73
-
(2006)
Int. J. Cancer
, vol.118
, pp. 62-73
-
-
Silvertown, J.D.1
Ng, J.2
Sato, T.3
Summerlee, A.J.4
Medin, J.A.5
-
13
-
-
33845422046
-
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens
-
Thompson V.C., Morris T.G., Cochrane D.R., Cavanagh J., Wafa L.A., Hamilton T., et al. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens. Prostate 66 (2006) 1698-1709
-
(2006)
Prostate
, vol.66
, pp. 1698-1709
-
-
Thompson, V.C.1
Morris, T.G.2
Cochrane, D.R.3
Cavanagh, J.4
Wafa, L.A.5
Hamilton, T.6
-
14
-
-
34447132814
-
Skeletal remodeling in health and disease
-
Zaidi M. Skeletal remodeling in health and disease. Nat. Med. 13 (2007) 791-801
-
(2007)
Nat. Med.
, vol.13
, pp. 791-801
-
-
Zaidi, M.1
-
15
-
-
42049110350
-
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease
-
Kearns A.E., Khosla S., and Kostenuik P.J. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29 (2008) 155-192
-
(2008)
Endocr. Rev.
, vol.29
, pp. 155-192
-
-
Kearns, A.E.1
Khosla, S.2
Kostenuik, P.J.3
-
16
-
-
23644459100
-
Does human relaxin-2 affect peripheral blood mononuclear cells to increase inflammatory mediators in pathologic bone loss?
-
Kristiansson P., Holding C., Hughes S., and Haynes D. Does human relaxin-2 affect peripheral blood mononuclear cells to increase inflammatory mediators in pathologic bone loss?. Ann. N. Y. Acad. Sci. 1041 (2005) 317-319
-
(2005)
Ann. N. Y. Acad. Sci.
, vol.1041
, pp. 317-319
-
-
Kristiansson, P.1
Holding, C.2
Hughes, S.3
Haynes, D.4
-
17
-
-
33645635391
-
Relaxin stimulates leukocyte adhesion and migration through a relaxin receptor LGR7-dependent mechanism
-
Figueiredo K.A., Mui A.L., Nelson C.C., and Cox M.E. Relaxin stimulates leukocyte adhesion and migration through a relaxin receptor LGR7-dependent mechanism. J. Biol. Chem. 281 (2006) 3030-3039
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 3030-3039
-
-
Figueiredo, K.A.1
Mui, A.L.2
Nelson, C.C.3
Cox, M.E.4
-
18
-
-
64549135098
-
Role of relaxin in human osteoclastogenesis
-
Facciolli A., Ferlin A., Gianesello L., Pepe A., and Foresta C. Role of relaxin in human osteoclastogenesis. Ann. N. Y. Acad. Sci. 1160 (2009) 221-225
-
(2009)
Ann. N. Y. Acad. Sci.
, vol.1160
, pp. 221-225
-
-
Facciolli, A.1
Ferlin, A.2
Gianesello, L.3
Pepe, A.4
Foresta, C.5
-
19
-
-
42449137005
-
Mutations in the insulin-like factor 3 receptor are associated with osteoporosis
-
Ferlin A., Pepe A., Gianesello L., Garolla A., Feng S., Giannini S., et al. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J. Bone Miner. Res. 23 (2008) 683-693
-
(2008)
J. Bone Miner. Res.
, vol.23
, pp. 683-693
-
-
Ferlin, A.1
Pepe, A.2
Gianesello, L.3
Garolla, A.4
Feng, S.5
Giannini, S.6
-
20
-
-
23044434673
-
Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts
-
Dempster D.W., Hughes-Begos C.E., Plavetic-Chee K., Brandao-Burch A., Cosman F., Nieves J., et al. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J. Cell. Biochem. 95 1 (2005) 139-148
-
(2005)
J. Cell. Biochem.
, vol.95
, Issue.1
, pp. 139-148
-
-
Dempster, D.W.1
Hughes-Begos, C.E.2
Plavetic-Chee, K.3
Brandao-Burch, A.4
Cosman, F.5
Nieves, J.6
-
21
-
-
4344623297
-
Biology of primate relaxin: a paracrine signal in early pregnancy?
-
Hayes E.S. Biology of primate relaxin: a paracrine signal in early pregnancy?. Reprod. Biol. Endocrinol. 16 (2004) 2-36
-
(2004)
Reprod. Biol. Endocrinol.
, vol.16
, pp. 2-36
-
-
Hayes, E.S.1
-
22
-
-
34250181702
-
Relaxin promotes prostate cancer progression
-
Feng S., Agoulnik I.U., Bogatcheva N.V., Kamat A.A., Kwabi-Addo B., Li R., et al. Relaxin promotes prostate cancer progression. Clin. Cancer Res. 13 (2007) 1695-1702
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 1695-1702
-
-
Feng, S.1
Agoulnik, I.U.2
Bogatcheva, N.V.3
Kamat, A.A.4
Kwabi-Addo, B.5
Li, R.6
-
23
-
-
33845939640
-
Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes
-
Halls M.L., Bathgate R.A., and Summers R.J. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes. J. Pharmacol. Exp. Ther. 320 (2007) 281-290
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.320
, pp. 281-290
-
-
Halls, M.L.1
Bathgate, R.A.2
Summers, R.J.3
-
25
-
-
33846031926
-
The molecular understanding of osteoclast differentiation
-
Asagiri M., and Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 40 2 (2007) 251-264
-
(2007)
Bone
, vol.40
, Issue.2
, pp. 251-264
-
-
Asagiri, M.1
Takayanagi, H.2
-
27
-
-
34547138680
-
Influence of receptor activator of nucleus factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CFS) and fetal calf serum on human osteoclast formation and activity
-
Kreja L., Liedert A., Schmidt C., Claes L., and Ignatius A. Influence of receptor activator of nucleus factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CFS) and fetal calf serum on human osteoclast formation and activity. J. Mol. Histol. 38 (2007) 341-345
-
(2007)
J. Mol. Histol.
, vol.38
, pp. 341-345
-
-
Kreja, L.1
Liedert, A.2
Schmidt, C.3
Claes, L.4
Ignatius, A.5
-
28
-
-
36348941863
-
Bone metastasis: pathogenesis and therapeutic implications
-
Clezardin P., and Teti A. Bone metastasis: pathogenesis and therapeutic implications. Clin. Exp. Metastasis 24 (2007) 599-608
-
(2007)
Clin. Exp. Metastasis
, vol.24
, pp. 599-608
-
-
Clezardin, P.1
Teti, A.2
-
29
-
-
0028828701
-
Characterization of human relaxin gene regulation in the relaxin-expressing human prostate adenocarcinoma cell line LNCaP.FGC
-
Gunnersen J.M., Roche P.J., Tregear G.W., and Crawford R.J. Characterization of human relaxin gene regulation in the relaxin-expressing human prostate adenocarcinoma cell line LNCaP.FGC. J. Mol. Endocrinol. 15 (1995) 153-166
-
(1995)
J. Mol. Endocrinol.
, vol.15
, pp. 153-166
-
-
Gunnersen, J.M.1
Roche, P.J.2
Tregear, G.W.3
Crawford, R.J.4
-
30
-
-
33746588199
-
Relaxin enhances the oncogenic potential of human thyroid carcinoma cells
-
Hombach-Klonisch S., Bialek J., Trojanowicz B., Weber E., Holzhausen H.J., Silvertown J.D., et al. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells. Am. J. Pathol. 169 (2006) 617-632
-
(2006)
Am. J. Pathol.
, vol.169
, pp. 617-632
-
-
Hombach-Klonisch, S.1
Bialek, J.2
Trojanowicz, B.3
Weber, E.4
Holzhausen, H.J.5
Silvertown, J.D.6
-
31
-
-
37549070672
-
Cysteine cathepsin proteases as pharmacological targets in cancer
-
Palermo C., and Joyce J.A. Cysteine cathepsin proteases as pharmacological targets in cancer. Trends. Pharmacol. Sci. 29 (2008) 22-28
-
(2008)
Trends. Pharmacol. Sci.
, vol.29
, pp. 22-28
-
-
Palermo, C.1
Joyce, J.A.2
-
32
-
-
3242882918
-
Disparate effects of relaxin and TGFbeta1: relaxin increases, but TGFbeta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells
-
Mazella J., Tang M., and Tseng L. Disparate effects of relaxin and TGFbeta1: relaxin increases, but TGFbeta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells. Hum. Reprod. 19 (2004) 1513-1518
-
(2004)
Hum. Reprod.
, vol.19
, pp. 1513-1518
-
-
Mazella, J.1
Tang, M.2
Tseng, L.3
-
33
-
-
33645932334
-
The human relaxin receptor (LGR7): expression in the fetal membranes and placenta
-
Lowndes K., Amano A., Yamamoto S., and Bryant-Greenwood G.D. The human relaxin receptor (LGR7): expression in the fetal membranes and placenta. Placenta 27 (2006) 610-618
-
(2006)
Placenta
, vol.27
, pp. 610-618
-
-
Lowndes, K.1
Amano, A.2
Yamamoto, S.3
Bryant-Greenwood, G.D.4
|